{"id":254,"date":"2026-03-23T16:27:01","date_gmt":"2026-03-23T20:27:01","guid":{"rendered":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/?p=254"},"modified":"2026-03-23T16:27:01","modified_gmt":"2026-03-23T20:27:01","slug":"the-federal-trade-commission-forms-healthcare-task-force-to-address-competition-in-healthcare-markets","status":"publish","type":"post","link":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2026\/03\/23\/the-federal-trade-commission-forms-healthcare-task-force-to-address-competition-in-healthcare-markets\/","title":{"rendered":"The Federal Trade Commission Forms Healthcare Task Force to Address Competition in Healthcare Markets"},"content":{"rendered":"\n<p>The Federal Trade Commission (FTC) has formed a <a href=\"https:\/\/www.ftc.gov\/system\/files\/ftc_gov\/pdf\/Memorandum-Ferguson-re-Healthcare-Task-Force.pdf\" data-type=\"link\" data-id=\"https:\/\/www.ftc.gov\/system\/files\/ftc_gov\/pdf\/Memorandum-Ferguson-re-Healthcare-Task-Force.pdf\">Healthcare Task Force<\/a> to focus on competition and consumer protection issues in healthcare markets and to develop policy recommendations aimed at improving healthcare market practices. The memorandum establishing the Task Force describes its mandate, structure and intended workstreams.<\/p>\n\n\n\n<p><strong>Implications for Healthcare Market Participants<\/strong><\/p>\n\n\n\n<p>The Task Force is intended to provide a more coordinated and systematic framework for the FTC\u2019s work in this sector, aligning enforcement, research and policy to address emerging and persistent issues in healthcare competition and consumer protection.<\/p>\n\n\n\n<p>The memorandum signals that the FTC will continue to prioritize healthcare as a core enforcement and policy area. Market participants \u2013 including providers, payers, intermediaries, and other healthcare entities \u2013 can expect:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Continued scrutiny of transactions, joint ventures and contracting practices that may affect competition.<\/li>\n\n\n\n<li>Ongoing attention to representations and business practices that may mislead or harm healthcare consumers.<\/li>\n\n\n\n<li>Increased emphasis on policy development and advocacy that may shape future regulatory and enforcement approaches in healthcare markets.<\/li>\n<\/ul>\n\n\n\n<!--more-->\n\n\n\n<p><strong>Overview of the Healthcare Task Force<\/strong><\/p>\n\n\n\n<p>The Healthcare Task Force is designed as an internal, cross\u2011disciplinary body within the FTC, drawing on staff and expertise from across the agency. Its creation reflects the Commission\u2019s recognition that healthcare markets present complex and evolving competition and consumer protection challenges, including issues arising from consolidation, vertical integration, payment and reimbursement structures, and the conduct of a range of market participants.<\/p>\n\n\n\n<p><strong>Key Objectives<\/strong><\/p>\n\n\n\n<p>According to the memorandum, the Healthcare Task Force will:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Identify and analyze competition issues in healthcare markets, including conduct and structures that may harm competition or lead to higher prices, reduced quality or diminished innovation.<\/li>\n\n\n\n<li>Examine consumer protection concerns in healthcare, including misleading or deceptive practices that may affect patients, purchasers, and other healthcare consumers.<\/li>\n\n\n\n<li>Coordinate and integrate the FTC\u2019s enforcement, research, advocacy and policy efforts relating to healthcare.<\/li>\n\n\n\n<li>Develop policy recommendations and best practices to promote fair and effective competition and to protect consumers in healthcare markets.<\/li>\n<\/ul>\n\n\n\n<p><strong>Scope of Work<\/strong><\/p>\n\n\n\n<p>The Task Force\u2019s work is expected to encompass:<\/p>\n\n\n\n<ul class=\"wp-block-list\">\n<li>Ongoing and potential enforcement matters involving alleged anticompetitive conduct or unfair or deceptive practices in healthcare markets.<\/li>\n\n\n\n<li>Empirical and policy research on healthcare market dynamics, including the effects of market structure, contracting practices, and information flows on competition and consumers.<\/li>\n\n\n\n<li>Development of guidance, reports, and other policy statements to inform market participants, policymakers and the public about the FTC\u2019s views on healthcare competition and consumer protection issues.<\/li>\n\n\n\n<li>Coordination with other federal and state entities, as appropriate, on overlapping or complementary healthcare policy and enforcement initiatives.<\/li>\n<\/ul>\n\n\n\n<p>Healthcare companies should closely monitor further Task Force developments and consult with experienced counsel to help navigate this enforcement landscape.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Federal Trade Commission (FTC) has formed a Healthcare Task Force to focus on competition and consumer protection issues in healthcare markets and to develop policy recommendations aimed at improving healthcare market practices. The memorandum establishing the Task Force describes its mandate, structure and intended workstreams. Implications for Healthcare Market Participants The Task Force is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/blogs.duanemorris.com\/antitrustlaw\/2026\/03\/23\/the-federal-trade-commission-forms-healthcare-task-force-to-address-competition-in-healthcare-markets\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;The Federal Trade Commission Forms Healthcare Task Force to Address Competition in Healthcare Markets&#8221;<\/span><\/a><\/p>\n","protected":false},"author":660,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"ppma_author":[9,101,37,8,96],"class_list":["post-254","post","type-post","status-publish","format-standard","hentry","category-general"],"authors":[{"term_id":9,"user_id":660,"is_guest":0,"slug":"spmcconnell","display_name":"Sean P. McConnell","avatar_url":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-content\/uploads\/sites\/68\/2025\/10\/mcconnellsean-100x100.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":101,"user_id":754,"is_guest":0,"slug":"kspeegle","display_name":"Katie Speegle","avatar_url":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-content\/uploads\/sites\/68\/2026\/02\/speeglekatie-100x100.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":37,"user_id":341,"is_guest":0,"slug":"chcasey","display_name":"Christopher H. Casey","avatar_url":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-content\/uploads\/sites\/68\/2024\/02\/caseychris-100x100.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":8,"user_id":659,"is_guest":0,"slug":"sckulik","display_name":"Sarah O'Laughlin Kulik","avatar_url":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-content\/uploads\/sites\/68\/2024\/02\/kuliksaraholaughlin-1-100x100.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""},{"term_id":96,"user_id":745,"is_guest":0,"slug":"nkalandadze","display_name":"Nina Kalandadze","avatar_url":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-content\/uploads\/sites\/68\/2025\/10\/kalandadzenina-100x100.jpg","0":null,"1":"","2":"","3":"","4":"","5":"","6":"","7":"","8":""}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/254","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/users\/660"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/comments?post=254"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/posts\/254\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/media?parent=254"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/categories?post=254"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/tags?post=254"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/antitrustlaw\/wp-json\/wp\/v2\/ppma_author?post=254"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}